Crispr Therapeutics Ag (CRSP)

SG&A Expense Growth

-10.07%

Quarterly · Period ending:

CRSP logo

CRSP SG&A Expense Growth

Latest reported-10.07%
CRSP Quarterly SG&A Growth (QoQ) (0.00% → -10.07%)
High-resolution chart · PNG

CRSP sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-10.0681%
-6.6091%
8.6705%
-10.4938%
-1.9693%
6.4666%
4.0473%
-10.5847%
8.5111%
8.9447%
-9.9065%
-3.8934%
-14.8837%
5.6262%
-21.5992%
2.7709%
-6.2382%
18.3419%
-0.1308%
-17.6942%
17.494%
-4.8475%
19.6249%
0.8711%
9.2225%
13.189%
11.2958%
-1.5791%
5.6199%
-9.7509%
62.5749%
-20.1397%
44.1942%
-21.9641%
39.5833%
4.4284%
-10.1134%
-28.4721%
194.1807%
-53.0682%
43.0837%
-1.9715%
154.3416%
14.6798%
-16.8351%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.